EVALUATING THE THERAPEUTIC POTENTIAL OF CARDIAC GLYCOSIDES AGAINST MEDULLOBLASTOMA

$128,349FY2020Defense Health AgencyDOD

Childrens Hospital Medical Center

Investigators

View source on USAspending →